• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Biogen Inc. (BIIB)

    -NasdaqGS
    303.69 Down 0.80(0.26%) Aug 28, 4:00PM EDT
    |After Hours : 303.55 Down 0.14 (0.05%) Aug 28, 4:57PM EDT
    Add to Portfolio
    Prev Close:304.49
    Open:301.00
    Bid:298.00 x 100
    Ask:314.40 x 300
    1y Target Est:389.27
    Beta:0.411391
    Earnings Date:Oct 20 - Oct 26 (Est.)
    Day's Range:299.76 - 306.45
    52wk Range:265.00 - 480.18
    Volume:2,059,085
    Avg Vol (3m):2,325,620
    Market Cap:71.42B
    P/E (ttm):20.57
    EPS (ttm):14.76
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BIIBDown 0.26%71.42B
    ABTUp 0.83%68.59B
    PFEDown 1.80%201.43B

    Key Statistics

    Forward P/E (1 yr):17.08
    P/S (ttm):6.95
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :15.92
    Quarterly EPS Est (Sep-15) :3.92
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):1.22

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback